Anthony Keefe

Dr. Anthony Keefe


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Open access
JGJohn P. Guilinger
John P. Guilinger
AAArchna Archna
Archna Archna
MAMartin Augustin
Martin Augustin
ABAndreas Bergmann
Andreas Bergmann
PCPaolo A. Centrella
Paolo A. Centrella
AKAnthony Keefe
Anthony Keefe
Libraries of DNA-Encoded small molecules created using combinatorial chemistry and synthetic oligonucleotides are being applied to drug discovery projects across the pharmaceutical industry. The majority of reported projects describe the discovery of reversible, i.e. non-covalent, target modulators. We synthesized multiple DNA-encoded chemical libraries terminated in electrophiles and then used them to discover covalent irreversible inhibitors and report the successful discovery of acrylamide- and epoxide-terminated Bruton's Tyrosine Kinase (BTK) inhibitors. We also demonstrate their selectivity, potency and covalent cysteine engagement using a range of techniques including X-ray crystallography, thermal transition shift assay, reporter displacement assay and intact protein complex mass spectrometry. The epoxide BTK inhibitors described here are the first ever reported to utilize this electrophile for this target.

27 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
ALAlexander Litovchick
Alexander Litovchick
XTXia Tian
Xia Tian
MMMichael I. Monteiro
Michael I. Monteiro
KKKaitlyn M. Kennedy
Kaitlyn M. Kennedy
MGMarie-Aude Guié
Marie-Aude Guié
AKAnthony Keefe
Anthony Keefe
Inspired by the many reported successful applications of DNA-encoded chemical libraries in drug discovery projects with protein targets, we decided to apply this platform to nucleic acid targets. We used a 120-billion-compound set of 33 distinct DNA-encoded chemical libraries and affinity-mediated selection to discover binders to a panel of DNA targets. Here, we report the successful discovery of small molecules that specifically interacted with DNA G-quartets, which are stable structural motifs found in G-rich regions of genomic DNA, including in the promoter regions of oncogenes. For this study, we chose the G-quartet sequence found in the c-myc promoter as a primary target. Compounds enriched using affinity-mediated selection against this target demonstrated high-affinity binding and high specificity over DNA sequences not containing G-quartet motifs. These compounds demonstrated a moderate ability to discriminate between different G-quartet motifs and also demonstrated activity in a cell-based assay, suggesting direct target engagement in the cell. DNA-encoded chemical libraries and affinity-mediated selection are uniquely suited to discover binders to targets that have no inherent activity outside of a cellular context, and they may also be of utility in other nucleic acid structural motifs.

22 January 2014 in Artificial DNA: PNA & XNA
Verified
Journal Article
Open access
ALAlexander Litovchick
Alexander Litovchick
MCMatthew A Clark
Matthew A Clark
AKAnthony Keefe
Anthony Keefe
The affinity-mediated selection of large libraries of DNA-encoded small molecules is increasingly being used to initiate drug discovery programs. We present universal methods for the encoding of su...

1 June 2015 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
AKAnthony Keefe
Anthony Keefe
MCMatthew A Clark
Matthew A Clark
CHChristopher D Hupp
Christopher D Hupp
ALAlexander Litovchick
Alexander Litovchick
YZYing Zhang
Ying Zhang

5 April 2024 in ACS Infectious Diseases
Verified
Journal Article
Open access
IKInna V. Krieger
Inna V. Krieger
SYSubbarao Yalamanchili
Subbarao Yalamanchili
PDPaige Dickson
Paige Dickson
CECurtis A. Engelhart
Curtis A. Engelhart
MZMatthew D Zimmerman
Matthew D Zimmerman
JSJames C Sacchettini
James C Sacchettini
DNA-encoded chemical library (DEL) technology provides a time- and cost-efficient method to simultaneously screen billions of compounds for their affinity to a protein target of interest. Here we report its use to identify a novel chemical series of inhibitors of the thioesterase activity of polyketide synthase 13 (Pks13) from Mycobacterium tuberculosis (Mtb). We present three chemically distinct series of inhibitors along with their enzymatic and Mtb whole cell potency, the measure of on-target activity in cells, and the crystal structures of inhibitor-enzyme complexes illuminating their interactions with the active site of the enzyme. One of these inhibitors showed a favorable pharmacokinetic profile and demonstrated efficacy in an acute mouse model of tuberculosis (TB) infection. These findings and assay developments will aid in the advancement of TB drug discovery.